Aethlon Medical, Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aethlon Medical, Inc. on September 12, 2025. The report addresses Item 8.01 (Other Events) regarding the company's capital structure following a recent financing activity.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only quantitative metric disclosed is the share count.
- Outstanding Shares: 7,373,156 as of the close of business on September 12, 2025.
Material Changes
The company completed a best-efforts public offering. As a result of this financing, the total number of outstanding shares is now 7,373,156. No other material changes to operations or financial position are detailed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of specific risks and contingencies beyond the disclosure of the recent financing event.
Investor Verification Checklist
- Verify the total proceeds raised from the "best-efforts public offering" referenced in the filing.
- Confirm the price per share at which the new shares were issued to calculate dilution impact.
- Review the company's most recent 10-Q or 10-K for current cash balances and burn rate, as this 8-K does not disclose liquidity figures.